Dany Raad, MD
Gastroenterology · Highland Hills, OHNPI 1659687721
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $324,940 of the $387,086 with a category attached, or 83.9%. 32 manufacturers reported payments, led by Sanofi at 54.1% of the total. 2025 is the largest year on record at $154,942, more than ten times the $521 reported in 2019. Among gastroenterology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 584 payments — averaging $662.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$209K
- Regeneron Healthcare Solutions, Inc.$123K
- Phathom Pharmaceuticals, Inc.$47K
- Takeda Pharmaceuticals U.S.A., Inc.$3K
- AbbVie$2K
- Braintree Laboratories, Inc.$523
- plus $2K from 26 others
What the payments were for
- Consulting fees$6,5102%
- Speaking & faculty fees$324,94084%
- Travel & lodging$41,79411%
- Food & beverage$13,8434%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 150 | $209,297 |
| Regeneron Healthcare Solutions, Inc. | 105 | $123,234 |
| Phathom Pharmaceuticals, Inc. | 79 | $47,125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $2,805 |
| AbbVie | 96 | $1,613 |
| Braintree Laboratories, Inc. | 6 | $523 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 21 | $356 |
| Pfizer | 13 | $274 |
| Johnson & Johnson(2 entities) | 14 | $268 |
| Madrigal Pharmaceuticals | 12 | $222 |
| Lilly USA, LLC | 8 | $191 |
| Nestle Healthcare Nutrition Inc. | 13 | $179 |
| Bristol Myers Squibb | 8 | $125 |
| Endogastric Solutions, Inc | 1 | $112 |
| Ferring Pharmaceuticals Inc. | 5 | $79 |
| Covidien LP | 1 | $74 |
| Aimmune Therapeutics, Inc. | 3 | $70 |
| Celltrion USA Inc. | 4 | $68 |
| Organon | 2 | $64 |
| Merck | 3 | $63 |
| Ardelyx, Inc. | 3 | $55 |
| QOL Medical, LLC | 3 | $52 |
| Ironwood Pharmaceuticals, Inc | 3 | $43 |
| Lucid Diagnostics Inc. | 2 | $32 |
| Redhill Biopharma Inc. | 2 | $27 |
| Shionogi Inc | 2 | $23 |
| Amgen | 1 | $23 |
| Intercept Pharmaceuticals, Inc. | 1 | $23 |
| Integra Lifesciences Corporation | 1 | $21 |
| Olympus America Inc. | 1 | $17 |
| Evoke Pharma, Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$387,086 in reported general payments places this provider in the 95th percentile of 657 gastroenterology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 17 | $28,238 |
| LinzessLinaclotide | 35 | $18,937 |
| VoqueznaVonoprazan Fumarate | 14 | $12,200 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 130 | $8,003 |
| Mesalamine | 12 | $4,509 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 23 | $3,701 |
| Omeprazole | 328 | $3,693 |
| Budesonide DrBudesonide | 25 | $3,494 |
| Pantoprazole Sodium | 136 | $1,799 |
| Azathioprine | 20 | $940 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 54 | $633 |
| Mercaptopurine | 14 | $564 |
| Dicyclomine Hcl | 23 | $542 |
| Famotidine | 19 | $346 |
| Amitriptyline Hcl | 22 | $337 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess | $1,613 | $47,17552 claims |
| Phathom Pharmaceuticals, Inc.Voquezna | $47,125 | $12,20014 claims |
| Braintree Laboratories, Inc.Sutab | $523 | $3,70123 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 657 gastroenterology providers in Ohio.
Other gastroenterology in Highland Hills
- Seth SclairHighland Hills$64K
- Naim AlkhouriWestlake$1.9M
- Pierre GholamCleveland$1.6M
- Anita AfzaliCincinnati$798K
- Mohamed NaemWestlake$708K
- Kara de FeliceCincinnati$427K
- Tasos ManokasColumbus$411K
- Florian RiederCleveland$396K
- Allan PeckCincinnati$391K
- Stanley CohenCleveland$338K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.